CRA II/Senior CRA - Early Phase
ICON is a global healthcare intelligence and clinical research organisation united by a mission to bring new medicines and treatments to patients faster.
As a values-driven organisation, integrity, collaboration, agility, and inclusion are at the heart of how we work and interact with each other, customers, patients and suppliers.
As a CRA II or Senior CRA within our Early Phase team, you'll play a critical role in studies that sit at the very beginning of the drug development journey, including first-in-human and proof-of-concept research. Working alongside leading investigators, sponsors, and specialist clinical teams, you'll help advance promising new therapies from concept to clinical reality.
Unlike traditional large-scale monitoring roles, you'll focus on a smaller portfolio of approximately 3-4 sites across the UK, enabling you to build strong site relationships, maintain exceptional quality oversight, and make a genuine impact on the success of each study.
Employment with ICON is contingent upon having the legal right to work in the country where the role is based.
ICON offers a competitive and comprehensive total rewards package designed to support your health, wellbeing, and career development.
Benefits may include:
Benefits may vary depending on role and location.
Visit our careers site to read more about the benefits ICON offers.
ICON is an equal opportunity employer. We are committed to building an inclusive and accessible workplace where everyone feels valued and supported.
If you require reasonable accommodations during the recruitment process, please let us know or submit a request here.
Are you a current ICON Employee? Please click here to apply

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times.
We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.